| AEs | Adverse Events |
| AMNOG | Arzneimittelmarkt-Neuordnungsgesetz (German Pharmaceuticals Market Reorganisation Act) |
| CE | Cost Effectiveness |
| EMA | European Medicines Agency |
| EQ-5D | EuroQoL-5D questionnaire |
| EU | European Union |
| HTDs | Health Technology Developers |
| HRQoL | Health-Related Quality of Life |
| IQWiG | Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (German Institute for Quality and Efficiency in Health Care) |
| LLMs | Large Language Models |
| JCA | Joint Clinical Assessment |
| NICE | National Institute for Health and Care Excellence |
| NMA | Network Meta-Analysis |
| PICO | Population/Intervention/Comparator/Outcome |
| QALYs | Quality Adjusted Life Years |
| OS | Overall Survival |
| PFS/DFS/RFS | Progression/Disease/Relapse-Free Survival |
| VAS | Visual Analogue Scale |